Literature DB >> 11158295

SH2 domain-mediated interaction of inhibitory protein tyrosine kinase Csk with protein tyrosine phosphatase-HSCF.

B Wang1, S Lemay, S Tsai, A Veillette.   

Abstract

The protein tyrosine kinase (PTK) Csk is a potent negative regulator of several signal transduction processes, as a consequence of its exquisite ability to inactivate Src-related PTKs. This function requires not only the kinase domain of Csk, but also its Src homology 3 (SH3) and SH2 regions. We showed previously that the Csk SH3 domain mediates highly specific associations with two members of the PEP family of nonreceptor protein tyrosine phosphatases (PTPs), PEP and PTP-PEST. In comparison, the Csk SH2 domain interacts with several tyrosine phosphorylated molecules, presumed to allow targetting of Csk to sites of Src family kinase activation. Herein, we attempted to understand better the regulation of Csk by identifying ligands for its SH2 domain. Using a modified yeast two-hybrid screen, we uncovered the fact that Csk associates with PTP-HSCF, the third member of the PEP family of PTPs. This association was documented not only in yeast cells but also in a heterologous mammalian cell system and in cytokine-dependent hemopoietic cells. Surprisingly, the Csk-PTP-HSCF interaction was found to be mediated by the Csk SH2 domain and two putative sites of tyrosine phosphorylation in the noncatalytic portion of PTP-HSCF. Transfection experiments indicated that Csk and PTP-HSCF synergized to inhibit signal transduction by Src family kinases and that this cooperativity was dependent on the domains mediating their association. Finally, we obtained evidence that PTP-HSCF inactivated Src-related PTKs by selectively dephosphorylating the positive regulatory tyrosine in their kinase domain. Taken together, these results demonstrate that part of the function of the Csk SH2 domain is to mediate an inducible association with a PTP, thereby engineering a more efficient inhibitory mechanism for Src-related PTKs. Coupled with previously published observations, these data also establish that Csk forms complexes with all three known members of the PEP family.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11158295      PMCID: PMC99562          DOI: 10.1128/MCB.21.4.1077-1088.2001

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  43 in total

Review 1.  Src family tyrosine kinases and growth factor signaling.

Authors:  C L Abram; S A Courtneidge
Journal:  Exp Cell Res       Date:  2000-01-10       Impact factor: 3.905

2.  Transmembrane phosphoprotein Cbp regulates the activities of Src-family tyrosine kinases.

Authors:  M Kawabuchi; Y Satomi; T Takao; Y Shimonishi; S Nada; K Nagai; A Tarakhovsky; M Okada
Journal:  Nature       Date:  2000-04-27       Impact factor: 49.962

3.  Post-translational alterations of the tyrosine kinase p56lck in response to activators of protein kinase C.

Authors:  A Veillette; I D Horak; J B Bolen
Journal:  Oncogene Res       Date:  1988-05

4.  Mutational analysis of Lck in CD45-negative T cells: dominant role of tyrosine 394 phosphorylation in kinase activity.

Authors:  U D'Oro; K Sakaguchi; E Appella; J D Ashwell
Journal:  Mol Cell Biol       Date:  1996-09       Impact factor: 4.272

5.  Enhancement of T-cell responsiveness by the lymphocyte-specific tyrosine protein kinase p56lck.

Authors:  N Abraham; M C Miceli; J R Parnes; A Veillette
Journal:  Nature       Date:  1991-03-07       Impact factor: 49.962

6.  The CD4 and CD8 T cell surface antigens are associated with the internal membrane tyrosine-protein kinase p56lck.

Authors:  A Veillette; M A Bookman; E M Horak; J B Bolen
Journal:  Cell       Date:  1988-10-21       Impact factor: 41.582

7.  Disruption of the csk gene, encoding a negative regulator of Src family tyrosine kinases, leads to neural tube defects and embryonic lethality in mice.

Authors:  A Imamoto; P Soriano
Journal:  Cell       Date:  1993-06-18       Impact factor: 41.582

8.  Phosphoprotein associated with glycosphingolipid-enriched microdomains (PAG), a novel ubiquitously expressed transmembrane adaptor protein, binds the protein tyrosine kinase csk and is involved in regulation of T cell activation.

Authors:  T Brdicka; D Pavlistová; A Leo; E Bruyns; V Korínek; P Angelisová; J Scherer; A Shevchenko; I Hilgert; J Cerný; K Drbal; Y Kuramitsu; B Kornacker; V Horejsí; B Schraven
Journal:  J Exp Med       Date:  2000-05-01       Impact factor: 14.307

9.  SH2 domains prevent tyrosine dephosphorylation of the EGF receptor: identification of Tyr992 as the high-affinity binding site for SH2 domains of phospholipase C gamma.

Authors:  D Rotin; B Margolis; M Mohammadi; R J Daly; G Daum; N Li; E H Fischer; W H Burgess; A Ullrich; J Schlessinger
Journal:  EMBO J       Date:  1992-02       Impact factor: 11.598

10.  Differential regulation of T cell antigen responsiveness by isoforms of the src-related tyrosine protein kinase p59fyn.

Authors:  D Davidson; L M Chow; M Fournel; A Veillette
Journal:  J Exp Med       Date:  1992-06-01       Impact factor: 14.307

View more
  13 in total

Review 1.  Reciprocal regulation of lymphocyte activation by tyrosine kinases and phosphatases.

Authors:  Michelle L Hermiston; Zheng Xu; Ravindra Majeti; Arthur Weiss
Journal:  J Clin Invest       Date:  2002-01       Impact factor: 14.808

2.  Protein tyrosine and serine-threonine phosphatases in the sea urchin, Strongylocentrotus purpuratus: identification and potential functions.

Authors:  C A Byrum; K D Walton; A J Robertson; S Carbonneau; R T Thomason; J A Coffman; D R McClay
Journal:  Dev Biol       Date:  2006-08-25       Impact factor: 3.582

3.  Global phosphoproteomics reveals crosstalk between Bcr-Abl and negative feedback mechanisms controlling Src signaling.

Authors:  Liudmilla Rubbi; Björn Titz; Lauren Brown; Erica Galvan; Evangelia Komisopoulou; Sharon S Chen; Tracey Low; Martik Tahmasian; Brian Skaggs; Markus Müschen; Matteo Pellegrini; Thomas G Graeber
Journal:  Sci Signal       Date:  2011-03-29       Impact factor: 8.192

Review 4.  The application of modular protein domains in proteomics.

Authors:  Joshua A Jadwin; Mari Ogiue-Ikeda; Kazuya Machida
Journal:  FEBS Lett       Date:  2012-04-21       Impact factor: 4.124

5.  Synergistic regulation of immunoreceptor signaling by SLP-76-related adaptor Clnk and serine/threonine protein kinase HPK-1.

Authors:  J Yu; C Riou; D Davidson; R Minhas; J D Robson; M Julius; R Arnold; F Kiefer; A Veillette
Journal:  Mol Cell Biol       Date:  2001-09       Impact factor: 4.272

6.  Mutation of SH2B3 (LNK), a genome-wide association study candidate for hypertension, attenuates Dahl salt-sensitive hypertension via inflammatory modulation.

Authors:  Nathan P Rudemiller; Hayley Lund; Jessica R C Priestley; Bradley T Endres; Jeremy W Prokop; Howard J Jacob; Aron M Geurts; Eric P Cohen; David L Mattson
Journal:  Hypertension       Date:  2015-03-16       Impact factor: 10.190

7.  The Syk kinase SmTK4 of Schistosoma mansoni is involved in the regulation of spermatogenesis and oogenesis.

Authors:  Svenja Beckmann; Christin Buro; Colette Dissous; Jörg Hirzmann; Christoph G Grevelding
Journal:  PLoS Pathog       Date:  2010-02-12       Impact factor: 6.823

8.  The yeast split-ubiquitin membrane protein two-hybrid screen identifies BAP31 as a regulator of the turnover of endoplasmic reticulum-associated protein tyrosine phosphatase-like B.

Authors:  Bing Wang; Jerry Pelletier; Michel J Massaad; Annette Herscovics; Gordon C Shore
Journal:  Mol Cell Biol       Date:  2004-04       Impact factor: 4.272

9.  Functions of the Lyn tyrosine kinase in health and disease.

Authors:  Evan Ingley
Journal:  Cell Commun Signal       Date:  2012-07-17       Impact factor: 5.712

10.  The autoimmunity risk variant LYP-W620 cooperates with CSK in the regulation of TCR signaling.

Authors:  María Luisa de la Puerta; Antonio G Trinidad; María del Carmen Rodríguez; José María de Pereda; Mariano Sánchez Crespo; Yolanda Bayón; Andrés Alonso
Journal:  PLoS One       Date:  2013-01-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.